Danny Espinosa is recovered enough from his wrist injury to be activated from the disabled list, but the second baseman was so bad before being shut down and so bad during his rehab assignment that the Nationals have decided to option him to Triple-A.
Anthony Rendon hitting .338 filling in for Espinosa at second base no doubt played a big part too, but Espinosa was 2-for-17 with 10 strikeouts in six rehab games and hit .158 in 44 games for the Nationals before the DL stint.
Espinosa has talked about liking to work with Triple-A hitting coach Troy Gingrich, who has him studying lots of video of his swing, but unless the Nationals decide that Rendon can’t hack it defensively at second base it could be tough for Espinosa to re-enter their plans.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.